- Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy (“DMD”)
- Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
- Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy
- Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
- Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
- Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
More ▼
Key statistics
On Friday, Satellos Bioscience Inc (MSCLF:QBB) closed at 0.3764, 70.73% above the 52 week low of 0.2205 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.3725 |
---|---|
High | 0.4161 |
Low | 0.3721 |
Bid | -- |
Offer | -- |
Previous close | 0.4418 |
Average volume | 25.07k |
---|---|
Shares outstanding | 112.79m |
Free float | 98.73m |
P/E (TTM) | -- |
Market cap | 59.78m CAD |
EPS (TTM) | -0.1718 CAD |
Data delayed at least 15 minutes, as of Jul 05 2024 20:37 BST.
More ▼